Les complexités de la prise en charge de la paralysie du nerf facial dans le contexte des soins oculovisuels
Keywords:
Paralysie de Bell, paralysie du nerf facial, paralysie du septième nerf, neuropathie facialeAbstract
La paralysie du nerf facial est une affection neurologique relativement courante qui s’accompagne souvent de manifestations oculaires graves nécessitant un traitement. Bien que la paralysie du nerf facial soit le plus souvent idiopathique (lorsqu’elle est également connue sous le nom de paralysie de Bell), d’autres causes plus inquiétantes doivent être exclues. L’identification de l’étiologie exacte repose sur une localisation anatomique correcte. La prise en charge est généralement multidisciplinaire et comprend le diagnostic correct, le traitement des complications oculaires et souvent l’utilisation de médicaments oraux pour traiter la paralysie elle-même, comme le montre ce rapport de cas.
References
Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol. 2008 Jul;265(7):743-52. doi: 10.1007/s00405-008-0646-4. Epub 2008 Mar 27. PMID: 18368417; PMCID: PMC2440925.
Rahman I, Sadiq SA. Ophthalmic management of facial nerve palsy: a review. Surv Ophthalmol. 2007;52(2):121-144. doi:10.1016/j.survophthal.2006.12.009
Gilchrist JM. Seventh cranial neuropathy. Semin Neurol. 2009;29(1):5-13. doi:10.1055/s-0028-1124018
Bhatti MT, Schiffman JS, Pass AF, Tang RA. Neuro-ophthalmologic complications and manifestations of upper and lower motor neuron facial paresis. Curr Neurol Neurosci Rep. 2010;10(6):448-458. doi:10.1007/s11910-010-0143-1
Kline LB. Neuro-ophthalmology Chapter 11 In: Kline LB. 2009 2010 Basic and Clinical Science Course, Section 5 Neuro-Ophthalmology. San Francisco: American Academy of Ophthalmology; 2009: 283-288.
Hazin R, Azizzadeh B, Bhatti MT. Medical and surgical management of facial nerve palsy. Curr Opin Ophthalmol. 2009;20(6):440-450. doi:10.1097/ICU.0b013e3283313cbf
Lee JS, Kim YH. Epidemiological trends of Bell's palsy treated with steroids in Korea between 2008 and 2018. Muscle Nerve. 2021 Jun;63(6):845-851. doi: 10.1002/mus.27213. Epub 2021 Mar 13. PMID: 33651414.
Smith IS, Rechlin DP. Delayed diagnosis of neuroborreliosis presenting as bell palsy and meningitis. J Am Osteopath Assoc. 2010;110(8):441-444.
Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021;90:284-292. doi:10.1016/j.jocn.2021.06.016
Tamaki A, Cabrera CI, Li S, et al. Incidence of Bell Palsy in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):767-768. doi: 10.1001/jamaoto.2021.1266. Erratum in: JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):775. PMID: 34165518; PMCID: PMC8227441.
Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43(1):3-40. doi:10.1007/s10072-021-05662-9
Quesnel AM, Lindsay RW, Hadlock TA. When the bell tolls on Bell's palsy: finding occult malignancy in acute-onset facial paralysis. Am J Otolaryngol. 2010;31(5):339-342. doi:10.1016/j.amjoto.2009.04.003.
Veronezi RJ, Fernandes YB, Borges G, Ramina R. Long-term facial nerve clinical evaluation following vestibular schwannoma surgery. Arq Neuropsiquiatr. 2008;66(2A):194-198. doi:10.1590/s0004-282x2008000200010.
Huang CC, Tseng FY, Chen ZC, et al. Malignant parotid tumor and facial palsy. Otolaryngol Head Neck Surg. 2007;136(5):778-782. doi:10.1016/j.otohns.2006.10.043.
Morales DR, Donnan PT, Daly F, Staa TV, Sullivan FM. Impact of clinical trial findings on Bell's palsy management in general practice in the UK 2001-2012: interrupted time series regression analysis. BMJ Open. 2013;3(7):e003121. Published 2013 Jul 16. doi:10.1136/bmjopen-2013-003121
Dong SH, Jung AR, Jung J, et al. Recurrent Bell's palsy. Clin Otolaryngol. 2019 May;44(3):305-312. doi: 10.1111/coa.13293. Epub 2019 Feb 22. PMID: 30672667.
Amer TA, El-Minawi HM, El-Shazly MI. Low-level versus high-level placement of gold plates in the upper eyelid in patients with facial palsy. Clin Ophthalmol. 2011;5:891-895. doi:10.2147/OPTH.S21491.
Gire A, Kwok A, Marx DP. PROSE treatment for lagophthalmos and exposure keratopathy. Ophthalmic Plast Reconstr Surg. 2013;29(2):e38-e40. doi:10.1097/IOP.0b013e3182674069
Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006283. doi: 10.1002/14651858.CD006283.pub3. PMID: 22161401.
Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016;7(7):CD001942. Published 2016 Jul 18. doi:10.1002/14651858.CD001942.pub5
Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019;9(9):CD001869. Published 2019 Sep 5. doi:10.1002/14651858.CD001869.pub9
Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7(11):993-1000. doi:10.1016/S1474-4422(08)70221-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Yelena Smart, Nicole Riese, Malinda Cafiero, Cathy Marques
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
